The European Union says vaccine maker AstraZeneca has agreed to supply 9 million additional doses to the 27-nation bloc during the first quarter.
The new target of 40 million doses by the end of March is still only half what the company had originally aimed for, triggering a spat between AstraZeneca and the EU last week.
European Commission President Ursula von der Leyen said late Sunday that the British-Swedish pharmaceutical maker will also begin deliveries one week sooner than scheduled and expand its manufacturing capacity in Europe.
